Targeting strategies for renal cancer stem cell therapy

Pengchao Fang, Liuting Zhou, Lee Y. Lim, Hualin Fu, Zhi Xiang Yuan, Juchun Lin

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)


Renal cell carcinoma (RCC) is an intractable genitourinary malignancy that accounts for approximately 4% of adult malignancies. Currently, there is no approved targeted therapy for RCC that has yielded dura-ble remissions, and they remain palliative in intent. Emerging evidence has indicated that renal tumorigenesis and RCC treatment-resistance may originate from renal cancer stem cells (CSCs) with tumor-initiating capacity (CSC hypothesis). A better understanding of the mechanism underlying renal CSCs will help to dissect RCC heterogeneity and drug treatment efficiency, to promote more personalized and targeted therapies. In this review, we summarized the stem cell characteristics of renal CSCs. We outlined the targeting strategies and challenges associated with developing therapies that target renal CSCs angiogenesis, immunosuppression, signaling pathways, surface biomarkers, microRNAs and nanomedicine. In conclusion, CSCs are an important role in renal carcino-genesis and represent a valid target for treatment of RCC patients.

Original languageEnglish
Pages (from-to)1964-1978
Number of pages15
JournalCurrent Pharmaceutical Design
Issue number17
Publication statusPublished - 2020


Dive into the research topics of 'Targeting strategies for renal cancer stem cell therapy'. Together they form a unique fingerprint.

Cite this